I lead clinical research strategy.
After we acquired Lokavant, our team delivered a fully integrated platform in just four months.
It was long overdue. In 2025 I was appointed to the SCRS Leadership Council.
From Merck to LillyTrials I tried everything and failed a ton. Always measure every outreach tactic.
Start small, bias toward action, and bring legal and downstream teams in early and often.
Jeff Kingsley of Centricity Research told me why "decentralized clinical trials" is a stupid term.
As a participant I had no less than five different numbers to reach someone at the site.
Running Lilly's wearable sensor studies on ProofPilot cut our costs 67%. I loved it so much, I joined.
A small cohort of us pharma folks pushed it along years ago. TransCelerate got it over the finish line.
I lead clinical research strategy.
After we acquired Lokavant, our team delivered a fully integrated platform in just four months.
It was long overdue. In 2025 I was appointed to the SCRS Leadership Council.
From Merck to LillyTrials I tried everything and failed a ton. Always measure every outreach tactic.
Start small, bias toward action, and bring legal and downstream teams in early and often.
Jeff Kingsley of Centricity Research told me why "decentralized clinical trials" is a stupid term.
As a participant I had no less than five different numbers to reach someone at the site.
Running Lilly's wearable sensor studies on ProofPilot cut our costs 67%. I loved it so much, I joined.
A small cohort of us pharma folks pushed it along years ago. TransCelerate got it over the finish line.
By using this service, you agree to the Terms of Service and Privacy Policy.